Evogene Ltd. (EVGN)
NASDAQ·Healthcare·Biotechnology
$0.57
-4.16%
Mkt Cap $6.67M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$3.50
Range $3.50 – $3.50
Implied Upside
+517.9%
Consensus $3.50 vs current $0.57
NASDAQ·Healthcare·Biotechnology
$0.57
-4.16%
Mkt Cap $6.67M
No recent rating data.
Price Target (2 analysts)
$3.50
Range $3.50 – $3.50
+517.9%
Consensus $3.50 vs current $0.57